Company Profile

Accudava Inc
Profile last edited on: 10/10/22      CAGE: 4GD16      UEI: LLG1HDTXS2Q4

Business Identifier: Personalized Molecular Cancer Diagnostics
Year Founded
2006
First Award
2017
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8241 La Jolla Scenic Drive North
La Jolla, CA 92037
   (858) 597-2008
   N/A
   www.accudava.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

AccuDava has developed a molecular process to improve the efficacy of personalizing cancer chemotherapy - effectively enabling physicians to avoid ineffective drugs and select suitable treatments, based on a patient’s tumor molecular characteristics. The firm's technology is based on the identification of two “Cell Surface Glycan Biomarkers” : Glycans beingthe dynamic molecules involved in cell signaling -- the front line of cell communication and defense. Specificlally the AccuDava Biomarker is on the cell surface not within the cell and is a carbohydrate motif, not genomic or pr

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NIH $497,265
Project Title: Novel Glyco-tests to Predict Chemoresistance

Key People / Management

  Nahid Razi -- President, CEO andFounder

Company News

There are no news available.